LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

导出 OA

翻译打印收藏纠错

作者： Feng-Jiao,Gan ^[1] ; Yi,Li ^[2] ; Meng-Xi,Xu ^[1] ; Tie,Zhou ^[1] ; Shun,Wu ^[1] ; Kang,Hu ^[1] ; Yan,Li ^[1] ; Su-Hong,Sun ^[1] ; Qing,Luo ^[1]

作者单位： Department of Thyroid and Breast Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. ^[1] Department of Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. ^[2]

关键词 LncRNA BCAR4 Locally advanced breast cancer clinical complete response neoadjuvant chemotherapy pathological complete response

主题词乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);人类(Humans);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy)

DOI 10.3233/CBM-210048

PMID 34151842

发布时间 2022-02-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer biomarkers

2021年32卷3期

339-351页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Cancer biomarkers

相似文献

Cancer biomarkers

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

LncRNA BCAR4 expression predicts the clinical response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.

Cancer biomarkers

相似文献

Cancer biomarkers

相关期刊

检索历史清除